mc2therapeutics.com
  • Home
  • About
    • Management
    • Board of Directors
    • Career
    • Download Center
  • Psoriasis
  • Products
  • Pipeline
    • MC2-03 PAD™ Eye Drop Sjogren Syndrome Dry Eye
    • MC2-25 PAD™ Cream – Uremic Pruritus
    • MC2-27 PAD™ Cream – Lichen Sclerosus
    • MC2-11 PAD™ Cream – Atopic Dermatitis
    • MC2-22 PAD™ Cream Atopic Dermatitis
  • Platform
  • News & Events
  • Investors
  • CONTACT
  • Search
  • Menu Menu

Single Portfolio: Fullscreen Slider

Pages

  • About us
  • Ann Kristin Led
  • Board of Directors
  • Career
  • Christopher S. Billis
  • CONTACT
  • Download Center
  • Frédéric Gomez
  • Home
  • Investors
  • Jesper J. Lange
  • Johan Selmer
  • Lonni Goltermann
  • Management
  • MC2 Therapeutics A/S appoints Anders D. Hove and Paul L. Berns to the Board of Directors
  • MC2-01 PAD™ Cream – Psoriasis1
  • MC2-03 PAD™ Eye Drop – Dry eyes
  • MC2-11 PAD™ Cream – Atopic dermatitis
  • MC2-16 PAD™ Cream – Psoriasis
  • MC2-21 PAD™ Cream – Dry and itchy skin
  • Morten Præstegaard
  • News
  • Pipeline
  • Pipeline Overview
  • Pipeline Overview – test
  • Platform
  • Products
  • Psoriasis
  • Rikke Pordel Vind
  • Wynzora® Cream – Psoriasis

Categories

  • No categories

Archive

    • Home
    • About
      • Management
      • Board of Directors
      • Career
      • Download Center
    • Psoriasis
    • Products
    • Pipeline
      • MC2-03 PAD™ Eye Drop Sjogren Syndrome Dry Eye
      • MC2-25 PAD™ Cream – Uremic Pruritus
      • MC2-27 PAD™ Cream – Lichen Sclerosus
      • MC2-11 PAD™ Cream – Atopic Dermatitis
      • MC2-22 PAD™ Cream Atopic Dermatitis
    • Platform
    • News & Events
    • Investors
    • CONTACT
    © mc2 therapeutics 2020
    Scroll to top